Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A RCT
This study has been completed.
Sponsored by: Stony Brook University
Information provided by: Stony Brook University
ClinicalTrials.gov Identifier: NCT00790270
  Purpose

The purpose of this study is to see whether the combination of a muscle relaxant and anti-inflammatory drug is more effective at relieving pain in patients with neck strains or whiplash than either of the two medications alone.


Condition Intervention Phase
Cervical Strain
Drug: Cyclobenzaprine
Drug: Ibuprofen
Drug: Ibuprofen plus Cyclobenzaprine
Phase II

Drug Information available for: Ibuprofen Dexibuprofen Cyclobenzaprine Cyclobenzaprine hydrochloride
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Comparison of Ibuprofen, Cyclobenzaprine, or Both for Acute Cervical Strain: A RCT

Further study details as provided by Stony Brook University:

Primary Outcome Measures:
  • Pain [ Time Frame: Daily for 1 week ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Time to resumption of work [ Time Frame: 1 week ] [ Designated as safety issue: No ]

Enrollment: 61
Study Start Date: January 2003
Study Completion Date: January 2004
Primary Completion Date: January 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Cyclobenzaprine: Active Comparator Drug: Cyclobenzaprine
5 mg orally every 8 hours as needed
Ibuprofen: Active Comparator Drug: Ibuprofen
Ibuprofen 400 mg every 8 hours as needed
Ibuprophen plus Cyclobenzaprine: Experimental Drug: Ibuprofen plus Cyclobenzaprine
Ibuprofen 400 mg plus cyclobenzaprine 5 mg every 8 hours as needed

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • neck pain within 24 hours of injury

Exclusion Criteria:

  • Children, allergy or contraindication to any of teh study drugs
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00790270

Locations
United States, New York
Stony Brook University
Stony Brook, New York, United States, 11733
Sponsors and Collaborators
Stony Brook University
Investigators
Principal Investigator: adam singer, md Stony Brook University
  More Information

Responsible Party: Stony Brook University ( Adam Singer, MD )
Study ID Numbers: SB2003-1234
Study First Received: November 12, 2008
Last Updated: November 12, 2008
ClinicalTrials.gov Identifier: NCT00790270  
Health Authority: United States: Institutional Review Board

Keywords provided by Stony Brook University:
Cervical strain
whiplash
ibuprofen
cyclobenzaprine

Study placed in the following topic categories:
Ibuprofen
Amitriptyline
Wounds and Injuries
Disorders of Environmental Origin
Neck Injuries
Whiplash Injuries
Cyclobenzaprine

Additional relevant MeSH terms:
Anti-Inflammatory Agents
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Adrenergic Uptake Inhibitors
Physiological Effects of Drugs
Psychotropic Drugs
Neuromuscular Agents
Sensory System Agents
Therapeutic Uses
Muscle Relaxants, Central
Anti-Inflammatory Agents, Non-Steroidal
Analgesics
Antidepressive Agents
Tranquilizing Agents
Cyclooxygenase Inhibitors
Central Nervous System Depressants
Enzyme Inhibitors
Pharmacologic Actions
Antidepressive Agents, Tricyclic
Analgesics, Non-Narcotic
Peripheral Nervous System Agents
Antirheumatic Agents
Central Nervous System Agents

ClinicalTrials.gov processed this record on January 16, 2009